Centrexion

Centrexion

Centrexion

We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.
Founded
2013
Raised
$95.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$11,160,000
Convertible Note - 2016
Team Size
1–10
Employees
MedCity News

Centrexion Therapeutics changes its mind on initial public offering

Xconomy

Centrexion Plans IPO to Bankroll Non-Opioid Pain Drugs

$67,000,000 Venture capital (Series D)
MedCity News

Centrexion's $67M Series D round to fund Phase 3 pain studies

$11,160,000 Convertible Note
venturedeal , sec

Centrexion Therapeutics Nets Venture Capital Debt

Funding